Martin C Michel
Overview
Explore the profile of Martin C Michel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
328
Citations
4904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dwaib H, Michel M
Biomolecules
. 2023 Dec;
13(12).
PMID: 38136585
β-Adrenoceptors mediate several functions in rodents that could be beneficial for the treatment of obesity and type 2 diabetes. This includes promotion of insulin release from the pancreas, cellular glucose...
12.
Alexander S, Christopoulos A, Davenport A, Kelly E, Mathie A, Peters J, et al.
Br J Pharmacol
. 2023 Dec;
180 Suppl 2:S23-S144.
PMID: 38123151
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of...
13.
Muderrisoglu A, de la Rosette J, Michel M
Expert Opin Drug Saf
. 2023 Dec;
22(12):1213-1224.
PMID: 38064204
Introduction: The drug classes of α-adrenoceptor antagonists, 5α-reductase inhibitors, and phosphodiesterase type 5 inhibitors are guideline-recommended treatments of lower urinary tract symptoms suggestive of benign prostatic hyperplasia; muscarinic receptor antagonists...
14.
Bschleipfer T, Abt S, Becher K, Dreikorn K, Hofner K, Madersbacher S, et al.
Urologie
. 2023 Oct;
62(10):1048-1056.
PMID: 37796278
Background: Lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH, in German guidelines: benign prostatic syndrome [BPS]) is considered the most common disease of the lower urinary tract...
15.
16.
Ashfaq A, Meineck M, Pautz A, Arioglu-Inan E, Weinmann-Menke J, Michel M
Pharmacol Ther
. 2023 Jul;
249:108503.
PMID: 37495021
We have performed a systematic review of studies reporting on the renal effects of SGLT2 inhibitors in rodent models of diabetes. In 105 studies, SGLT2 inhibitors improved not only the...
17.
Gravas S, Malde S, Cornu J, Gacci M, Gratzke C, Herrmann T, et al.
Prostate Cancer Prostatic Dis
. 2023 Jul;
27(1):48-53.
PMID: 37488274
No abstract available.
18.
Hennenberg M, Michel M
Handb Exp Pharmacol
. 2023 Jul;
285:333-367.
PMID: 37455288
Adrenoceptors importantly contribute to the physiological regulation of lower urinary tract (LUT) function and have become a target of several clinically successful treatments for major LUT diseases. In the bladder...
19.
Michel M
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445516
Benign conditions of the lower urinary tract, including benign prostatic hyperplasia, overactive bladder syndrome, and stress urinary incontinence, are frequent in the general population. Despite their benign nature, they have...
20.
Pautz A, Michel M
Handb Exp Pharmacol
. 2023 Jul;
282:57-74.
PMID: 37439844
Dysfunction of the lower urinary tract in general and the overactive bladder syndrome (OAB) in particular are prevalent and have major impact on the quality of life of the afflicted...